바로가기 메뉴
본문 바로가기
주메뉴 바로가기
소성준

소성준

비뇨의학과

전문과목

일반비뇨기, 배뇨장애, 요로결석

진료시간

월, 화, 수, 목, 금, 토
오전
오후
학력사항

2014년 경기고등학교 졸업

2020년 인제대학교 의과대학 학사 졸업

인제대학교 의과대학 석사 재학중


경력사항

2020년 인제대학교 부산백병원 인턴

2021년 3월 ~ 2026년 8월 인제대학교 부산백병원 비뇨의학과 레지던트 


주요활동


논문/저서

Gu HM, Sou SJ, Ku JY, Kim KH, Park YJ, Choi SH, Ha HK, Hwang EC, Lee CH. Impact of diabetes mellitus and hypertension on renal function during first-line targeted therapy for metastatic renal cell carcinoma: a retrospective multicenter study. Transl Androl Urol. 2024 Sep 30;13(9):1912-1921. doi: 10.21037/tau-24-231. Epub 2024 Sep 26. PMID: 39434726; PMCID: PMC11491201.


Sou SJ, Seo WI, Chung JI, Lee HS, Min KS, Jung SJ, Lee CH. Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy in nonmetastatic upper tract urothelial carcinoma with ≤pT2. Cent European J Urol. 2024;77(3):389-397. doi: 10.5173/ceju.2024.45.R1. Epub 2024 Sep 30. PMID: 40115471; PMCID: PMC11921937.


Lee HS, Min KS, Seo WI, Sou SJ, Chung JI, Jung SJ, Lee CH. Impact of variant histology in the prognosis of non muscle invasive bladder cancer with low tumor burden: A propensity score matched analysis with conventional urothelial carcinoma. Mol Clin Oncol. 2024 Sep 5;21(5):80. doi: 10.3892/mco.2024.2778. PMID: 39301124; PMCID: PMC11411584.


Sou SJ, Ku JY, Kim KH, Seo WI, Ha HK, Gu HM, Hwang EC, Park YJ, Lee CH. Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study. Investig Clin Urol. 2025 Mar;66(2):114-123. doi: 10.4111/icu.20240323. PMID: 40047124; PMCID: PMC11885917.